Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required.
Swift
P A
PA
Andrews
P A
PA
D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors